LUNGOV Trademark

Trademark Overview


On Tuesday, June 21, 2022, a trademark application was filed for LUNGOV with the United States Patent and Trademark Office. The USPTO has given the LUNGOV trademark a serial number of 79349653. The federal status of this trademark filing is REGISTERED as of Tuesday, October 31, 2023. This trademark is owned by XENOTHERA. The LUNGOV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, pharmaceuticals products for use in human or veterinary medicine for the prevention and treatment of infectious diseases; chemical preparations for medical or pharmaceutical use, namely, for the prevention and treatment of infectious diseases; diagnostic products for medical use, namely, diagnostic reagents and diagnostic biomarker reagents for use in human or veterinary medicine; chemical reagents for medical or veterinary use; monoclonal antibodies for medical and pharmaceutical use; pharmaceutical products and preparations for cell therapy, for the prevention and treatment of infectious diseases; biological preparations for use in human or veterinary medicine, or for pharmaceutical use for prevention and treatment of infectious diseases; microorganism cultures for use in human or veterinary medicine, or for pharmaceutical use; cell preparations for use in human or veterinary medicine, or for pharmaceutical use, in particular for gene therapy and ce...
lungov

General Information


Serial Number79349653
Word MarkLUNGOV
Filing DateTuesday, June 21, 2022
Status700 - REGISTERED
Status DateTuesday, October 31, 2023
Registration Number7204078
Registration DateTuesday, October 31, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2023

Trademark Statements


Goods and ServicesPharmaceutical products, namely, pharmaceuticals products for use in human or veterinary medicine for the prevention and treatment of infectious diseases; chemical preparations for medical or pharmaceutical use, namely, for the prevention and treatment of infectious diseases; diagnostic products for medical use, namely, diagnostic reagents and diagnostic biomarker reagents for use in human or veterinary medicine; chemical reagents for medical or veterinary use; monoclonal antibodies for medical and pharmaceutical use; pharmaceutical products and preparations for cell therapy, for the prevention and treatment of infectious diseases; biological preparations for use in human or veterinary medicine, or for pharmaceutical use for prevention and treatment of infectious diseases; microorganism cultures for use in human or veterinary medicine, or for pharmaceutical use; cell preparations for use in human or veterinary medicine, or for pharmaceutical use, in particular for gene therapy and cell therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameXENOTHERA
Party Type30 - Original Registrant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Party NameXENOTHERA
Party Type20 - Owner at Publication
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Party NameXENOTHERA
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Monday, February 26, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, February 5, 2024FINAL DISPOSITION NOTICE SENT TO IB
Monday, February 5, 2024FINAL DISPOSITION PROCESSED
Wednesday, January 31, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 31, 2023REGISTERED-PRINCIPAL REGISTER
Monday, August 21, 2023NOTIFICATION PROCESSED BY IB
Tuesday, August 15, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 2, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 2, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 26, 2023REFUSAL PROCESSED BY IB
Thursday, June 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 6, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 6, 2023REFUSAL PROCESSED BY MPU
Monday, April 10, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, April 9, 2023NON-FINAL ACTION WRITTEN
Saturday, April 1, 2023ASSIGNED TO EXAMINER
Tuesday, September 20, 2022APPLICATION FILING RECEIPT MAILED
Friday, September 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 15, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB